Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,630.00
Bid: 2,610.00
Ask: 2,625.00
Change: 60.00 (2.33%)
Spread: 15.00 (0.575%)
Open: 2,525.00
High: 2,630.00
Low: 2,525.00
Prev. Close: 2,570.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Steve Crummett as Finance Director

10 Jan 2013 07:00

RNS Number : 2188V
Morgan Sindall Group PLC
10 January 2013
 



 

10 January 2013

 

Morgan Sindall Group plc: Appointment of Steve Crummett as Finance Director

 

The Board of Morgan Sindall Group plc ('Morgan Sindall' or the 'Group') today announces the appointment of Steve Crummett as Finance Director with effect from 25 February 2013. Current Finance Director, David Mulligan, has indicated that, after fifteen years with the Group, he would like to step down from his current role to pursue new challenges and, with the appointment of Steve Crummett, he will be leaving the Group on 10 April 2013 following a handover period.

 

Steve Crummett was most recently the Group Finance Director at Filtrona plc, a position he held from 2008. Prior to Filtrona, Steve held senior positions in a number of listed companies including Exel plc, Mckechnie plc and Logica plc. He qualified as a Chartered Accountant with Arthur Andersen. Steve is also a Non-Executive Director of Consort Medical plc.

 

Chairman, Adrian Martin, said:

 

'On behalf of the Board I would like to thank David Mulligan for his significant contribution and commitment to Morgan Sindall over the past fifteen years. In his time with us, David has been instrumental in developing strong reporting disciplines and controls and has been a collaborative and supportive member of the team.

 

I am delighted that we have recruited a person of Steve Crummett's calibre as Finance Director. He has gained substantial and wide-ranging experience across a number of businesses and has valuable and significant skills which are relevant to Morgan Sindall as the business continues to focus on growth opportunities for the medium to longer-term.'

 

 

 

-Ends -

 

There are no further details to be disclosed pursuant to Listing Rule 9.6.13 in connection with Mr Crummett's appointment.

 

 

Morgan Sindall Group plc Tel: 020 7307 9200

Adrian Martin, Chairman

John Morgan, Chief Executive

 

Brunswick Tel: 0207 404 5959

Jonathan Glass

Nick Cosgrove

 

Notes to Editors:

 

Biography of Steve Crummett

 

From March 2008 to September 2012, Steve was the Group Finance Director of Filtrona plc, the FTSE 250 leading supplier of specialty plastic, fibre and foam products and was responsible for Finance, Tax, Treasury, IT, Internal Audit and Risk. From May 2007 to March 2008 he was Director of Corporate Development at Filtrona. Prior to Filtrona, Steve was at Exel plc from 2003 to 2006, through its acquisition by Deutsche Post. From 1997 to 2002, Steve was Head of Corporate Development at McKechnie plc, and Corporate Finance Manager at Logica plc from 1995 to 1997. He qualified as a Chartered Accountant with Arthur Andersen.

 

Morgan Sindall Group plc is a leading UK construction and regeneration group with a turnover of £2 billion, employing around 7,000 employees and operating in the public and commercial sectors. It operates through five divisions of construction and infrastructure, affordable housing, fit out, urban regeneration and investments.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADMGGMLLVGFZM
Date   Source Headline
23rd Apr 20218:49 amRNSHolding(s) in Company
22nd Apr 20213:33 pmRNSDirector/PDMR Shareholding
22nd Apr 20217:00 amRNSTrading Update
21st Apr 20219:21 amRNSBlock listing Interim Review
9th Apr 20214:03 pmRNSDirector/PDMR Shareholding
8th Apr 20218:00 amRNSDirectorate Change
1st Apr 202111:59 amRNSTotal Voting Rights
25th Mar 202112:51 pmRNSAnnual Financial Report
12th Mar 20214:37 pmRNSHolding(s) in Company
11th Mar 20214:55 pmRNSDirector/PDMR Shareholding
10th Mar 20213:01 pmRNSDirector/PDMR Shareholding
8th Mar 20214:54 pmRNSDirector/PDMR Shareholding
8th Mar 20214:28 pmRNSDirector/PDMR Shareholding
5th Mar 20213:06 pmRNSDirector/PDMR Shareholding
1st Mar 202111:25 amRNSTotal Voting Rights
25th Feb 20217:00 amRNSFinal Results
17th Feb 20219:06 amRNSHolding(s) in Company
8th Feb 20217:00 amRNSNotice of Results
3rd Feb 20213:42 pmRNSHolding(s) in Company
1st Feb 202110:40 amRNSTotal Voting Rights
22nd Jan 20214:58 pmRNSHolding(s) in Company
4th Jan 202110:56 amRNSTotal Voting Rights
8th Dec 20202:00 pmRNSAdditional Listing
7th Dec 20209:23 amRNSDirector Declaration
3rd Dec 20203:20 pmRNSDirector/PDMR Shareholding
1st Dec 202012:55 pmRNSTotal Voting Rights
4th Nov 20203:00 pmRNSDividend Declaration
4th Nov 20207:00 amRNSTrading Update
2nd Nov 202012:24 pmRNSTotal Voting Rights
20th Oct 20209:57 amRNSBlock listing Interim Review
1st Oct 20201:28 pmRNSTotal Voting Rights
23rd Sep 20205:00 pmRNSHolding(s) in Company
18th Sep 202012:02 pmRNSPrice Monitoring Extension
15th Sep 202010:00 amRNSAdditional Listing
9th Sep 20202:49 pmRNSHolding(s) in Company
2nd Sep 202012:07 pmRNSSecond Price Monitoring Extn
2nd Sep 202012:02 pmRNSPrice Monitoring Extension
1st Sep 20209:11 amRNSTotal Voting Rights
25th Aug 20204:06 pmRNSHolding(s) in Company
21st Aug 20204:15 pmRNSHolding(s) in Company
6th Aug 202012:25 pmRNSHolding(s) in Company
5th Aug 20207:00 amRNSHalf-year Report
3rd Aug 20209:54 amRNSTotal Voting Rights
27th Jul 20207:00 amRNSForward funding secured for £185m New Victoria
14th Jul 20208:30 amRNS£252m forward funding deal of Lewisham Gateway
7th Jul 20203:21 pmRNSHolding(s) in Company
6th Jul 20207:00 amRNSNotice of Results
1st Jul 20202:49 pmRNSHolding(s) in Company
1st Jul 20208:50 amRNSTotal Voting Rights
25th Jun 20203:29 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.